copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
YOUR GUIDE TO THE SUSVIMO® IMPLANT PROCEDURE The recommended dose of SUSVIMO (ranibizumab injection) is 2 mg (0 02 mL of 100 mg mL solution) continuously delivered via the SUSVIMO ocular implant with refills administered every 36 weeks (approximately 9 months)
SUSVIMO® Frequently Asked Questions | DME Treatment Get answers to frequently asked questions about SUSVIMO® (ranibizumab injection), an implant for diabetic macular edema (DME) See Full Safety and Boxed Warning for more information
Side Effects | SUSVIMO® (ranibizumab injection) Learn about possible side effects of SUSVIMO® (ranibizumab injection), a treatment option for wet AMD See Full Safety and Boxed Warning for more information
What is wet AMD? | SUSVIMO® (ranibizumab injection) SUSVIMO (ranibizumab injection) is delivered into the eye using the SUSVIMO implant The SUSVIMO implant and the procedures to insert, fill, refill, and remove the eye (ocular) implant can cause serious side effects, including:
PROCEDIMIENTO - susvimo. com La dosis recomendada de SUSVIMO (inyección de ranibizumab) es de 2 mg (0 02 ml de solución de 100 mg ml) administrada continuamente a través del implante ocular de SUSVIMO con recargas administradas cada 36 semanas (aproximadamente 9 meses)
SUSVIMO Wet AMD Brochure The recommended dose of SUSVIMO (ranibizumab injection) is 2 mg (0 02 mL of 100 mg mL solution) continuously delivered via the SUSVIMO ocular implant with refills administered every 24 weeks (approximately 6 months)